Table 3.

Adverse events

Adverse Event	Patients with Adverse Events (n)			Total Adverse Events (n)
	Losartan Group (n = 77)	Placebo Group (n = 76)	P Valuea	Losartan Group (n = 77)	Placebo Group (n = 76)	P Valueb
Bacterial infection	11	10	1.00	15	15	0.98
Cardiovascular	9	9	1.00	9	11	0.64
Death, unknown cause	2	0	0.50	2	0	NA
Digestive	8	14	0.17	15	18	0.70
Endocrine	10	18	0.10	10	28	0.01
Fungal/other infection	2	4	0.44	2	6	0.20
Hematologic	3	5	0.49	5	10	0.37
Musculoskeletal	14	9	0.37	19	12	0.31
Other/unknown	11	8	0.63	14	10	0.51
Rejection	7	8	0.79	12	9	0.63
Respiratory	3	5	0.49	7	6	0.86
Urogenital	12	21	0.08	16	26	0.14
Viral infection	5	8	0.40	6	8	0.59

NA, not applicable; can't be calculated due to small number of events.

^aFisher exact test.

^bNegative binomial test.